Hydrogen Gas Protects Brain During Surgery in Animal Study

Authors
Journal
Medical Gas Research
Year
DOI
10.1186/2045-9912-1-7
Study Type
Rat
Outcome
Positive
Peer Reviewed
Yes
Country
United States
Health Condition
Surgical Brain Injury
Body System
Nervous System

TL;DR

Hydrogen gas treatment reduced brain swelling and improved recovery without affecting stress and inflammation in rats after brain surgery.

Key Finding

Hydrogen gas (2.9%) administered during surgery significantly reduced brain swelling and improved neurological function in rats with surgical brain injury, though it did not reduce measured markers of oxidative stress or inflammation.

Summary

Researchers tested whether hydrogen gas could protect the brain from damage caused by surgery in rats. When rats underwent brain surgery, those treated with hydrogen gas (2.9%) developed less brain swelling and showed better neurological function 24 hours after surgery compared to untreated rats. Interestingly, the hydrogen didn't reduce the markers of oxidative stress (cellular damage from unstable molecules) or inflammation that the researchers measured, suggesting hydrogen may work through a different mechanism than expected.

Practical Takeaway

This rat study suggests hydrogen gas may have potential to reduce brain swelling after neurosurgery, but it is very early-stage research. The study was conducted only in animals, lasted just 24 hours, and the mechanism of benefit remains unclear. Much more research, including human trials, would be needed before any clinical applications could be considered.

Abstract

Neurosurgical operations cause unavoidable damage to healthy brain tissues. Direct surgical injury as well as surgically induced oxidative stress contributes to the subsequent formation of brain edema. Therefore, we tested the neuroprotective effects of hydrogen (H2) in an established surgical brain injury (SBI) model in rats. Adult male Sprague - Dawley rats (weight 300-350g) were divided into three groups to serve as sham operated, SBI without treatment, and SBI treated with H2 (2.9%). Brain water content, myeloperoxidase (MPO) assay, lipid peroxidation (LPO), and neurological function were measured at 24 hrs after SBI. SBI resulted in localized brain edema (p = < 0.001). Hydrogen (2.9%) administered concurrently with surgery significantly decreased the formation of cerebral edema (p = 0.028) and improved neurobehavioral score (p = 0.022). However, hydrogen treatment failed to reduce oxidative stress (LPO assay) or inflammation (MPO assay) in brain tissues. Hydrogen appears to be promising as an effective, yet inexpensive way to reduce cerebral edema caused by surgical procedures. Hydrogen has the potential to improve clinical outcome, decrease hospital stay, and reduce overall cost to patients and the health care system.